Tenofovir amibufenamide in chronic hepatitis B: Lipid changes and 144-week safety with tenofovir disoproxil fumarate-to-tenofovir amibufenamide switch.

World J Gastroenterol · 2025 · PMC12264858 · PMID 40678712

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

did not reach statistical significanceno p-value reported

While the mean levels of LDL and TG also showed a decreasing trend during TDF treatment, these differences did not reach statistical significance, possibly due to the limited sample size.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.